Par Drugs IPO Allotment Status Online

The Par Drugs IPO allotment status will be available on May 13, 2019, as per the timeline provided in the red-herring prospectus.

Below are the steps to check Par Drugs IPO allotment status online:

• Visit the Par Drugs IPO allotment status page.
• Click on the green Par Drugs IPO Allotment Status.
• Enter either PAN number, Application Number or DP Client ID of the demat account to check the Par Drugs IPO allotment status.
• Click Search.

Note: The disabled button shows that the allotment is not yet available online.

The allotment result looks like as below:

• PAN No.: AHMLK1898J
• Application No.: RL041213805307
• Name: Mr. Rajveer Singh
• Shares Applied: 40
• Shares Allotted: 40

The expected listing price of Par Drugs IPO depends on many factors including demand, nature of the business, market environment and state of the economy. The Par Drugs IPO grey market premium gives some hint but the actual listing price is difficult to guess.

Par Drugs IPO allotment status is expected on May 13, 2019. Click the green button Par Drugs IPO Allotment Status above to check the allotment. Note the button remains to disable until the allotment is available online.

If Par Drugs IPO oversubscribed in the retail category, the Par Drugs IPO shares will be distributed on a proportionate basis to Retail Individual Investors (RII). Each retail investor will get a minimum of 1 lot subject to the availability of shares in the retail portion. If enough shares are not available, a lottery is drawn to choose the investors.

The Par Drugs IPO shares will get listed on Thursday, May 16, 2019. The equity share of Par Drugs and Chemicals Limited will list on NSE SME.

The reason you didn't get the Par Drugs IPO could be:

• IPO become oversubscribed and allotment process is completed through a lottery
• The IPO application got rejected due to mismatch/incomplete information
• The issue price is higher than the bid price. (Always apply on cut-off price).

The Par Drugs IPO will open for bidding on May 3, 2019. The IPO application closes on May 8, 2019.